Modafinil Treatment for Sleep/Wake Disturbances in Older Adults
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Modafinil, trade named Provigil, is a medication approved by the Food and Drug Administration
for the treatment of narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work
sleep disorder. Each of these problems is characterized by difficulty sleeping at night and
excessive daytime sleepiness. Modafinil is prescribed during the day to counteract this
sleepiness. The idea behind this treatment is that sleepiness that leads to napping during
the day prevents a patient from being tired or sleepy enough to get good sleep at night. This
study is designed to determine if the medication can "reset" participants' sleep/wake rhythm
to a more normal rhythm.